Antibody + Drug + Third Party, Antibody + siRNAASO + Third Party

GLP 1 at Scale

The Increasing Importance of Manufacturability in API Development

AI in Pharmaceutical Manufacturing Operations

Navigating the Future

EDITORIAL SECTION

STRATEGY

Strategic Positioning for M&A

The biotechnology sector is characterised by a constant influx of small highly specialised companies

RESEARCH DEVELOPMENT

Cytiva Laboratory capsule filters

Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling

CLINICAL TRIALS

Virtual Clinical Trials

Virtual digital and decentralized are all descriptions of the novel ways that using technology changes

Bio Pharma

Biosimilars and Biobetters

Biosimilars are biologic medical products that are essentially identical to an original product manufactured

MANUFACTURING

Transformative Convergence of AI in Pharmaceutical Manufacturing

The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by

Information Technology

Transformative Impact of Artificial Intelligence on Clinical Trials

Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries

EXPERT Talk

Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems

My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...

Advisory Board

Victor M. Diaz Perez

Kishore Hotha

Joab Williamson

Scott M. Wheelwright

Tamara Miller

Juris Hmelnickis

David Contorno

Svetlana Busiguina

Eiman Shafa

Nigel Cryer FRSC

Hector Alejandro Andonie

Josipa Ljubicic

KNOWLEDGE BANK

Articles

Continuous Manufacturing: The New Standard for Agile Pharma Production

American pharmaceutical executives have spent the past several years managing consequences that trace back to a production model designed for a different century Shortages concentrated in older

Techno Trends

University Researchers Develop CAR T Therapy Candidate for Solid Tumour Treatment

Researchers from the University of Calgary and McMaster University have developed a novel CAR T cell therapy approach targeting treatmentresistant solid tumours

Projects

BeOne Medicines Invests US$300 Million to Expand New Jersey Manufacturing Campus

BeOne Medicines has announced a US million expansion of its Princeton West Innovation Campus in Hopewell New Jersey strengthening its US manufacturing and research capabilities

Research Insights

Thymidylate synthase inhibitory drugs induce p53-dependent pathways differently

Thymidylate synthase TS is a key enzyme in thymidylate biosynthesis and an established target of chemotherapeutics such as fluorodeoxyuridine FdUR and raltitrexed RTX Inhibition of TS disrupts

White Papers

Accelerating In-Vitro Antibody Discovery with Artificial Intelligence

Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities

press releasesRead more...

Photys Therapeutics and Polymed Biopharmaceuticals Announce the Initiation of a Phase I Clinical Trial of PHT-776/HPB-143, an Oral IRAK4 PROTAC Degrader

Photys Therapeutics Inc Photys a proximitybased therapeutics company and Polymed Biopharmaceuticals Inc Polymed a global biotech company focused on creating bestinclass PROTACs

U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse

Bristol Myers Squibb NYSE BMY today announced that the US Food and Drug Administration FDA has approved ZENBEXUS iberdomide in combination with daratumumab and hyaluronidasefihj

Vivodyne Launches the World’s Largest Human Biological Datacenter to Train the First World Model of Human Biology

Vivodyne the company making human biology computable at AI scale today announced the worlds largest human biological datacenter with robotic HIVE laboratories and the annual capacity to perform controlled

Novo Nordisk's Awiqli®, the first once-weekly basal insulin for adults with type 2 diabetes, now available in the US

Novo Nordisk today announced the nationwide launch of Awiqli insulin icodecabae injection unitsmL the first onceweekly basal insulin approved as an adjunct to diet and exercise